miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 11, 2026

Stock market today: Dow, S&P 500, Nasdaq end little changed as strong jobs report complicates Fed's rate path

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq end little changed as strong jobs report complicates Fed's rate path US stocks were little changed on Wednesday, as investors digested a January jobs report that blew past expectations on a monthly basis…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The January jobs report is the 'Super Bowl of jobs reports'.

    80% confidence

  • There is a 94.1% probability that the Fed will keep rates in their current range of 3.5%-3.75% at the March meeting, up from 79.9% a day prior.

    80% confidence

  • Kraft Heinz's challenges are fixable and within the company's control, and the $600 million investment will accelerate return to profitable growth.

    80% confidence

  • Vertiv expects momentum to continue in 2026 with record backlog providing clear visibility into another year of significant growth.

    80% confidence

  • Ship captains should remain as far as possible from Iran's territorial sea without compromising navigational safety.

    80% confidence

  • Smaller job gains in the labor market may be explained by a productivity boom.

    80% confidence

  • President Trump said he is thinking about sending a second US aircraft carrier to Middle Eastern waters.

    80% confidence

  • Economists characterized the jobs report release day with skepticism, calling it #ConspiracyTheoryJobsday.

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq end little changed as strong jobs report complicates Fed's rate path — Source | Via News | es.VIA.NEWS